Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05404945
Title Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Virginia
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.